Patricia and Rodes Hart Endowed Professor, Department of Urologic Surgery and Oncology, Vanderbilt University
Urology
Dr. Sam S. Chang, MD
|
|
Give Review
Chang practices Urology. He studied medicine at Vanderbilt University School of Medicine. He has 5 awards "America's Top Doctors", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Whos Who in Medicine and Healthcare". Chang has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.' He accepts all Medicare patients.
Publications
- Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care.
- Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality.
- Lack of P16ink4a over expression in Penile squamous cell carcinoma is associated with recurrence after lymph node dissection.
- Kidney Cancer, version 3.2015.
- Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
- Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive Bladder cancer, including carcinoma in situ of the Bladder.
- Renal Surgery and its Impact on Chronic Kidney Disease: A Continuing Evolution in Decision Making.
- Increasing utilization of neoadjuvant chemotherapy for muscle-invasive Bladder cancer in the United States.
- Safety of Hexaminolevulinate for Blue Light Cystoscopy in Bladder Cancer. A Combined Analysis of the Trials Used for Registration and Postmarketing Data.
- An Expressed Retrogene of the Master Embryonic Stem Cell Gene POU5F1 Is Associated with Prostate Cancer Susceptibility.
- Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
- Kidney Cancer, version 2.2014.
- Locoregional small cell carcinoma of the Bladder: clinical characteristics and treatment patterns.
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides.
- Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database.
- Treating octogenarians with muscle-invasive Bladder cancer: Preoperative opportunities for increasing the benefits of surgical intervention.
- Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device.
- Alvimopan, a peripherally acting mu-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, c...
- Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Ass...
- Racial variation in the quality of surgical care for Bladder cancer.
- Slipped capital femoral epiphysis caused by Neurogenic heterotopic ossification.
- The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for Bladder cancer.
- Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.
- Challenges in the pathology of non-muscle-invasive Bladder cancer: a dialogue between the urologic surgeon and the pathologist.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Non-muscle invasive Bladder cancer.
- Ureteroenteric anastomotic Strictures after radical cystectomy-does operative approach matter?
- Improvements in Safety and Recovery Following Cystectomy: Reassessing the Role of Pre-Operative Bowel Preparation and Interventions to Speed Return of Post-Operative B...
- Salvage robotic assisted laparoscopic radical Prostatectomy: a single institution, 5-year experience.
- Changes in protein characteristics during soybean storage under adverse conditions as related to tofu making.
- Optimizing outcomes for octogenarians with invasive Bladder cancer: One size does not fit all.
- 12th Annual meeting of the Society of Urologic Oncology (SUO) Bladder cancer sessions I and II summary report.
- ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the Bladder.
- Volume outcomes of cystectomy--is it the surgeon or the setting?
- Association of nonsteroidal anti-inflammatory drugs, Prostate specific antigen and Prostate volume.
- Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined Bladder cancer.
- Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Schools
Vanderbilt University School Of Medicine
Vanderbilt University Hospital
Memorial Sloan Kettering Cancer Center
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Atrophic Vaginitis
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Whos Who in Medicine and Healthcare
Education
-
Memorial Sloan-Kettering Cancer Center -
Vanderbilt University -
Vanderbilt University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1922107358 | |
| NPPES Provider LastName | CHANG | |
| NPPES Provider FirstName | SAM | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Urology | |
| Total Claim Count | 733.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 20.0 | |
| Percent Opioid Claims | 2.73 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922107358 |
| Last Name Of The Provider | CHANG |
| First Name Of The Provider | SAM |
| View All |
Similar Doctors
|
Dr. Sriram Dasari, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith W. Hagan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole L. Miller, MD |
|
|
Dr. Robert H. Edwards, MD |
|
|
Dr. John M. Tudor Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Herrell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Whitson Lowe Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Douglas C. Altenbern, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin L. Dehner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel Gosalbez, MD |
|
|
Dr. Herbert V. Braren, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Corinne L. Puzio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niels V. Johnsen, MD |
|
|
Dr. Harras B. Zaid, MD |
|
|
Dr. Christopher R. Mitchell, MD |
|
|
Lauren A. Combs, PA-C |